Related Experiment Video
Updated: Feb 16, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
The aliens inside us: HERV-W endogenous retroviruses and multiple sclerosis
1Department of Biomedical Sciences, University of Sassari, Sassari, Italy.
Abstract:
Two human endogenous retroviruses of the HERV-W family are proposed as multiple sclerosis (MS) co-factors: MS-associated retrovirus (MSRV) and ERVWE1, whose env proteins showed several potentially neuropathogenic features, in vitro and in animal models. Phase II clinical trials against HERV-Wenv are ongoing. HERV-W/MSRV was repeatedly found in MS patients, in striking parallel with MS stages, active/remission phases, and therapy outcome. The HERV-Wenv protein is highly expressed in active MS plaques. Early MSRV presence in spinal fluids predicted worst MS progression 10 years in advance. Effective anti-MS therapies strongly reduced MSRV/Syncytin-1/HERV-W expression. The Epstein-Barr virus (EBV) activates HERV-W/MSRV in vitro and in vivo, in patients with infectious mononucleosis and controls with high anti-EBNA1-IgG titers. Thus, the two main EBV/MS links (infectious mononucleosis and high anti-EBNA1-IgG titers) are paralleled by activation of HERV-W/MSRV. It is hypothesized that EBV may act as initial trigger of future MS, years later, by activating MSRV, which would act as direct neuropathogenic effector, before and during MS.
Insights
Human endogenous retroviruses (HERV-W) like MSRV are linked to multiple sclerosis (MS) progression. Epstein-Barr virus (EBV) activates HERV-W/MSRV, potentially triggering MS years later.
Area of Science:
- Immunology
- Virology
- Neuroscience
Background:
- Human endogenous retroviruses (HERV-W) and Epstein-Barr virus (EBV) are implicated in multiple sclerosis (MS) pathogenesis.
- HERV-W family members, including MS-associated retrovirus (MSRV) and ERVWE1, exhibit neuropathogenic potential in preclinical models.
Purpose of the Study:
- To investigate the association between HERV-W/MSRV and MS development and progression.
- To explore the role of EBV in activating HERV-W/MSRV in the context of MS.
Main Methods:
- Detection of HERV-W/MSRV in MS patients across different disease stages and in relation to therapy outcomes.
- Analysis of HERV-Wenv protein expression in active MS lesions.
- Assessment of EBV's in vitro and in vivo activation of HERV-W/MSRV.
Main Results:
- HERV-W/MSRV presence correlates with MS stages, activity, and therapy response.
- High expression of HERV-Wenv is observed in active MS plaques.
- Early MSRV detection in cerebrospinal fluid predicts long-term MS progression.
- Effective MS therapies reduce HERV-W/MSRV expression.
- EBV activates HERV-W/MSRV in infectious mononucleosis patients and individuals with high anti-EBNA1-IgG titers.
Conclusions:
- HERV-W/MSRV is a significant co-factor in MS, with its presence and expression correlating with disease activity and progression.
- EBV activation of HERV-W/MSRV may represent an early trigger for MS development years before clinical onset.
Related Concept Videos
Retroviruses
Retrovirus Life Cycles
Mechanisms of Retrovirus-induced Cancers
Multiple Allele Traits
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Multiple Regression
Farmers can use multiple regression to determine the crop yield based on more than one factor, such as water availability, fertilizer, soil properties, etc. Here, the crop yield is the response or dependent variable as it depends on the other independent variables. The analysis requires the construction of a scatter plot...

